The funding discussions highlight ongoing investor demand for new and unproven research labs looking to find novel approaches to AI that push the technology forward. Recursive’s goal is to develop ...

Boston University researchers in a groundbreaking study found that those with CTE have a much higher chance of being diagnosed with dementia. The largest study of its kind from the Boston University ...

Over 1 In 3 Ex-NFL Players Believe They Have CTE. From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the ...

Patients with advanced chronic traumatic encephalopathy (CTE), a brain disease likely caused by repeated head injuries, were more than four times as likely to develop dementia compared to those ...

Recursion's co-founder and long-serving chief executive, Chris Gibson, has switched to the role of company chair, and will be succeeded in the CEO role by R&D and commercial head Najat Khan. The ...

The former high school football player who killed four people inside a Manhattan office tower that houses the headquarters of the NFL, and who blamed the league for hiding the dangers of brain ...

Ricursive Intelligence, a startup building an AI system to design and automatically improve AI chips, has raised $300 million at a $4 billion valuation. The company said Monday the round was led by ...

Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company that combines automation, artificial intelligence, machine learning, and in vivo validation capabilities to discover novel ...